{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T21:52:12Z","timestamp":1770069132134,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[1993,1,1]],"date-time":"1993-01-01T00:00:00Z","timestamp":725846400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drug Ther"],"published-print":{"date-parts":[[1993,1]]},"DOI":"10.1007\/bf00877957","type":"journal-article","created":{"date-parts":[[2005,3,23]],"date-time":"2005-03-23T17:02:55Z","timestamp":1111597375000},"page":"45-53","source":"Crossref","is-referenced-by-count":21,"title":["Central hemodynamic effects of diuretic therapy in chronic heart failure"],"prefix":"10.1007","volume":"7","author":[{"given":"B.","family":"Silke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0002-8703(78)90303-4","volume":"95","author":"S Shah","year":"1978","unstructured":"Shah S, Khatri I, Freis D. Mechanism of antihypertensive effect of thiazide diuretics.Am Heart J 1978;95:611?618.","journal-title":"Am Heart J"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/archinte.1974.00320180077006","volume":"133","author":"L Tobian","year":"1974","unstructured":"Tobian L. Hypertension and the kidney.Arch Intern Med 1974;133:959?967.","journal-title":"Arch Intern Med"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/01.CIR.21.1.21","volume":"21","author":"J Conway","year":"1960","unstructured":"Conway J, Lauwers P. Hemodynamic and hypotensive effects of long-term therapy with chlorothiazide.Circulation 1960;21:21?27.","journal-title":"Circulation"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1161\/01.CIR.20.6.1028","volume":"20","author":"IM Wilson","year":"1959","unstructured":"Wilson IM, Freis ED. Relationship between plasma and extracellular fluid volume depletion and the anti-hypertensive effect of chlorothiazide.Circulation 1959;20:1020?1036.","journal-title":"Circulation"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/01.CIR.41.4.709","volume":"16","author":"RC Tarazi","year":"1970","unstructured":"Tarazi RC, Dustan HP, Frohlich ED. Long-term thiazide therapy in essential hypertension.Circulation 1970;16:709?717.","journal-title":"Circulation"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1161\/01.CIR.37.1.27","volume":"37","author":"JJ Bourgoignie","year":"1968","unstructured":"Bourgoignie JJ, Catanzaro FJ, Perry HM. Renin-angiotensin-aldosterone system during chronic thiazide therapy of benign hypertension.Circulation 1968;37:2793?2795.","journal-title":"Circulation"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/BF03029749","volume":"5","author":"P Lijnen","year":"1991","unstructured":"Lijnen P, Fagard R, Staessen J, Amery A. Hormonal effects of the diuretic xipamide in healthy men.Cardiovasc Drugs Ther 1991;5:741?746.","journal-title":"Cardiovasc Drugs Ther"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1056\/NEJM197305242882102","volume":"88","author":"K Dikshit","year":"1973","unstructured":"Dikshit K, Vyden JK, Forrester JS, et al. Renal and extrarenal haemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction.N Engl J Med 1973;88:1087?1090.","journal-title":"N Engl J Med"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/oxfordjournals.eurheartj.a061382","volume":"4","author":"GIC Nelson","year":"1983","unstructured":"Nelson GIC, Ahuja RC, Silke B, et al. Haemodynamic effects of frusemide and its influence on repetitive rapid volume loading in acute myocardial infarction.Eur Heart J 1983;4:706?711.","journal-title":"Eur Heart J"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2125.1987.tb03131.x","volume":"24","author":"SP Verma","year":"1987","unstructured":"Verma SP, Silke B, Reynolds G, et al. Immediate effects of bumetanide on systemic haemodynamics and left ventricular volume in acute and chronic heart failure.Br J Clin Pharmacol 1987;24:21?32.","journal-title":"Br J Clin Pharmacol"},{"key":"CR11","first-page":"11","volume":"8","author":"SH Taylor","year":"1983","unstructured":"Taylor SH, Storstein L. Diuretics in the treatment of heart failure.Herz 1983;8:11?22.","journal-title":"Herz"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1042\/cs0650359","volume":"65","author":"GD Johnston","year":"1983","unstructured":"Johnston GD, Nicholls DP, Leahey WJ, Finch MB. The effects of captopril on the acute vascular responses to frusemide in man.Clin Sci 1983;65:359?363.","journal-title":"Clin Sci"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2125.1986.tb05207.x","volume":"21","author":"GD Johnston","year":"1986","unstructured":"Johnston GD, Nicholls DP, Kondowe GB, Finch MB. Comparison of the acute vascular effects of frusemide and bumetanide.Br J Clin Pharmacol 1986;21:359?364.","journal-title":"Br J Clin Pharmacol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/hrt.31.6.711","volume":"31","author":"S Lal","year":"1969","unstructured":"Lal S, Murtagh JG, Pollock AM, et al. Acute haemodynamic effects of frusemide in patients with normal and raised left atrial pressure.Br Heart J 1969;31:711?717.","journal-title":"Br Heart J"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1161\/01.CIR.44.6.1014","volume":"44","author":"RM Davidson","year":"1971","unstructured":"Davidson RM, Goldman J, Whalen RE, Wallace AG. Haemodynamic effects of furosemide in acute myocardial infarction.Circulation 1971;44:157?158.","journal-title":"Circulation"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1161\/01.CIR.48.3.581","volume":"48","author":"J Kiely","year":"1973","unstructured":"Kiely J, Kelly DT, Taylor DR, Pitt B. The role of furosemide in the treatment of left ventricular dysfunction associated with acute myocardial infarction.Circulation 1973;48:581?587.","journal-title":"Circulation"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1136\/hrt.36.1.44","volume":"36","author":"H Mond","year":"1974","unstructured":"Mond H, Hunt D, Sloman G. Hemodynamic effects of frusemide in patients suspected of having acute myocardial infarction.Br Heart J 1974;36:44?53.","journal-title":"Br Heart J"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0002-9149(79)90049-3","volume":"43","author":"TL Biddle","year":"1979","unstructured":"Biddle TL, Yu PN. Effect of furosemide on haemodynamics and lung water in acute pulmonary oedema secondary to myocardial infarction.Am J Cardiol 1979;43:86?90.","journal-title":"Am J Cardiol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0140-6736(83)92025-1","volume":"1","author":"GIC Nelson","year":"1983","unstructured":"Nelson GIC, Silke B, Ahuja RC, et al. Haemodynamic advantages of isosorbide dinitrate over frusemide in acute heart failure following myocardial infarction.Lancet 1983;1:730?732.","journal-title":"Lancet"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/clpt.1982.127","volume":"32","author":"JA Franciosa","year":"1982","unstructured":"Franciosa JA, Silverstein SR, Wilen M. Hemodynamic effects of nitroprusside and furosemide in left ventricular failure.Clin Pharmacol Ther 1982;32:62?69.","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"CR21","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/cpt1977225part1499","volume":"22","author":"WM Bennett","year":"1977","unstructured":"Bennett WM, McDonald WJ, Kuehnel E, et al. Do diuretics have antihypertensive properties independent of natriuresis?Clin Pharmacol Ther 1977;22(5):499?504.","journal-title":"Clin Pharmacol Ther"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1161\/01.CIR.53.2.364","volume":"53","author":"SM Austin","year":"1976","unstructured":"Austin SM, Schreiner BF, Kramer DH, et al. The acute hemodynamic effects of ethacrynic acid and furosemide in patients with chronic post-capillary pulmonary hypertension.Circulation 1976;53:364?369.","journal-title":"Circulation"},{"key":"CR23","first-page":"551","volume":"49","author":"B Hesse","year":"1975","unstructured":"Hesse B, Nielsen I, Lund-Jacobsen H. The early effects of intravenous furosemide on central haemodynamics, venous tone, and plasma renin activity.Clin Sci Mol Med 1975;49:551?555.","journal-title":"Clin Sci Mol Med"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF00613811","volume":"24","author":"H Valette","year":"1983","unstructured":"Valette H, Hebert JL, Apoil E. Acute haemodynamic effects of a single intravenous dose of piretanide in congestive heart failure.Eur J Clin Pharmacol 1983;24:163?167.","journal-title":"Eur J Clin Pharmacol"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00005344-198003000-00002","volume":"2","author":"H Valette","year":"1990","unstructured":"Valette H, Hebert JL, Raffestin B, et al. Comparison of hemodynamic effects of furosemide and piretanide in normovolemic patients.J Cardiovasc Pharmacol 1990;2:103?111.","journal-title":"J Cardiovasc Pharmacol"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2125.1979.tb00925.x","volume":"7","author":"H Valette","year":"1979","unstructured":"Valette H, Duhaze P, Apoil E. Plethysmographic study with furosemide and piretanide in healthy volunteers (letter).Br J Clin Pharmacol 1979;7:219.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"CR27","first-page":"97","volume":"8","author":"H Fiehring","year":"1990","unstructured":"Fiehring H, Achhammer I. Influence of 10 mg torasemide i.v. and 20 mg furosemide i.v. on the intracardiac pressures in patients with heart failure at rest and during exercise.Prog Pharmacol Clin Pharmacol 1990;8(1):97?104.","journal-title":"Prog Pharmacol Clin Pharmacol"},{"issue":"1","key":"CR28","first-page":"137","volume":"8","author":"J Isbary","year":"1990","unstructured":"Isbary J, Achhammer I, Wetzels E. The influence of 20 mg torasemide i.v. and 20 mg furosemide i.v. on hemodynamics and diuresis in patients with high grade left heart failure.Prog Pharmacol Clin Pharmacol 1990;8(1):137?146.","journal-title":"Prog Pharmacol Clin Pharmacol"},{"issue":"1","key":"CR29","first-page":"147","volume":"8","author":"A-F Langbehn","year":"1990","unstructured":"Langbehn A-F, Achhammer I, B\u00f6lke T. Acute hemodynamic effects of 20 mg torasemide and 20 mg furosemide given intravenously to patients with congestive heart failure.Prog Pharmacol Clin Pharmacol 1990;8(1):147?155.","journal-title":"Prog Pharmacol Clin Pharmacol"},{"issue":"1","key":"CR30","first-page":"157","volume":"8","author":"T Podszus","year":"1990","unstructured":"Podszus T, Piesche L. Effect of torasemide on pulmonary and cardiac haemodynamics after oral treatment of chronic heart failure.Prog Pharmacol Clin Pharmacol 1990;8(1):157?166.","journal-title":"Prog Pharmacol Clin Pharmacol"},{"key":"CR31","first-page":"104","volume":"11","author":"V Ziacahi","year":"1981","unstructured":"Ziacahi V, Rossi A, Lomanto B. Modificazioni emodinamiche indoite dalla bumetanide endovenosa nello scompenso congestizio (Haemodynamic modifications induced by intravenous bumetanide in congestive heart failure).G Ital Cardiol 1981;11:104?109.","journal-title":"G Ital Cardiol"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/BF01857763","volume":"4","author":"W Haerer","year":"1990","unstructured":"Haerer W, Bauer U, Sultan N, et al. Acute and chronic effects of a diuretic monotherapy with piretanide in congestive heart failure?a placebo-controlled trial.Cardiovasc Drugs Ther 1990;4:515?522.","journal-title":"Cardiovasc Drugs Ther"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/BF03029746","volume":"5","author":"MD Cheitlin","year":"1991","unstructured":"Cheitlin MD, Byrd R, Benowitz N, et al. Amiloride improves hemodynamics in patients with chronic congestive heart failure treated with chronic digoxin and diuretics.Cardiovasc Drugs Ther 1991;5:719?726.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"1","key":"CR34","first-page":"121","volume":"8","author":"M Stauch","year":"1990","unstructured":"Stauch M, Stiehl L. Controlled double-blind clinical trial of the efficacy and tolerance of torasemide in comparison with furosemide in patients with congestive heart failure.Prog Pharmacol Clin Pharmacol 1990;8(1):121?126.","journal-title":"Prog Pharmacol Clin Pharmacol"},{"issue":"Suppl 2","key":"CR35","first-page":"27","volume":"74","author":"K Oversohl","year":"1985","unstructured":"Oversohl K, Mehrabian G, Hanisch M, Schmitz H. Muzolimine as monotherapy in the treatment of patients with congestive heart failure.Z Kardiol 1985;74(Suppl 2):27?31.","journal-title":"Z Kardiol"},{"issue":"Suppl 2","key":"CR36","first-page":"13","volume":"74","author":"S Dalla Volta","year":"1985","unstructured":"Dalla Volta S, Scognamiglio R, Sorbio MD, et al. Effect of muzolimine in aortic insufficiency with different levels of left ventricular function.Z Kardiol 1985;74(Suppl 2):13?18.","journal-title":"Z Kardiol"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0140-6736(88)90347-9","volume":"1","author":"N Sharpe","year":"1988","unstructured":"Sharpe N, Murphy J, Smith H, Hannan S. Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction.Lancet 1988;1:255?259.","journal-title":"Lancet"},{"issue":"Supp B","key":"CR38","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/eurheartj\/11.suppl_B.147","volume":"11","author":"N Sharpe","year":"1990","unstructured":"Sharpe N, Murphy J, Smith H, Hannan S. Preventive treatment of asymptomatic left ventricular function following myocardial infarction.Eur Heart J 1990;11(Supp B):147?156.","journal-title":"Eur Heart J"},{"issue":"1","key":"CR39","first-page":"105","volume":"8","author":"R D\u00fcsing","year":"1990","unstructured":"D\u00fcsing R, Piesche L. Second line therapy of congestive heart failure with torasemide.Prog Pharmacol Clin Pharmacol 1990;8(1):105?120.","journal-title":"Prog Pharmacol Clin Pharmacol"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00877957.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00877957\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00877957","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T08:57:29Z","timestamp":1556528249000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00877957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,1]]},"references-count":39,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[1993,1]]}},"alternative-id":["BF00877957"],"URL":"https:\/\/doi.org\/10.1007\/bf00877957","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,1]]}}}